The Truth Is Out There

Posts tagged ‘health’

China Conducts mRNA Influenza Bird Flu Vaccine Trials in Dairy Cows: Journal ‘Research’


Government preparation for large-scale mRNA vaccination of livestock.

Chinese government–funded researchers have confirmed that they tested an mRNA bird flu vaccine in lactating dairy cows, injecting milk-producing livestock with an mRNA–lipid nanoparticle formulation and then deliberately exposing the animals to live H5N1 influenza virus inside high-containment laboratories.

The peer-reviewed study published on Monday, in the journal Research, is titled “Protective Efficacy of a Hemagglutinin-Based mRNA Vaccine Against H5N1 Influenza Virus Challenge in Lactating Dairy Cows.”

The experiment signals that governments are actively preparing mRNA platforms for potential large-scale use in livestock populations, extending mRNA deployment beyond humans and into the food supply.

mRNA Vaccine Administered to Food-Producing Animals

According to the study, researchers injected an mRNA vaccine into lactating Holstein dairy cows, meaning animals actively producing milk.

The authors write:

“Six healthy lactating dairy cows were intramuscularly immunized with 500 μg of the mRNA vaccine twice, with a 3-week interval between doses.”

The animals were sourced from an external farm:

“Lactating Holstein cows, 3 to 5 years of age, obtained from a local dairy farm, were used in the challenge experiment.”

The vaccine was an mRNA–lipid nanoparticle (mRNA–LNP) formulation encoding the hemagglutinin protein of an avian influenza virus:

“We developed a monovalent, cattle-codon-optimized mRNA–LNP vaccine encoding the HA protein.”

Deliberate Infection with H5N1 Pathogen

After receiving the mRNA injections, both vaccinated and unvaccinated cows were moved into animal biosafety level 3+ (ABSL-3+) laboratories and deliberately infected with a purportedly live H5N1 influenza virus.

The paper states:

“3 vaccinated and 3 unvaccinated lactating dairy cows were transferred into the animal biosafety level 3+ (ABSL-3+) facility for the challenge study.”

The virus was said to be administered through multiple routes, including direct injection into the mammary glands:

“All cows received a DC/24 virus challenge administered via both the intranasal and intramammary routes.”

The authors further specify:

“3 doses were directly inoculated into separate mammary quarters via the teat.”

High-Containment Facilities & Lab-Generated Viruses

All work involving the pathogen was performed inside Chinese state-authorized high-containment laboratories.

The methods section states:

“The procedures involving live HPAI viruses were performed within certified BSL-3 and ABSL-3+ laboratories at the Harbin Veterinary Research Institute (HVRI), Chinese Academy of Agricultural Sciences (CAAS).”

The H5N1 viruses used were not simple field samples but laboratory-generated strains.

The authors cite a prior peer-reviewed study for the virus’s creation and laboratory handling methods, rather than detailing the generation process in this paper.

“The challenge dairy cow H5N1 virus (DC/24)… was generated as previously described.”

Chinese Government Funding

The study was funded entirely by Chinese state and government research programs.

The funding disclosure reads:

“This research was funded by the National Key Research and Development Program of China… the National Natural Science Foundation of China… the Innovation Program of the CAAS… the natural science foundation of Heilongjiang Province… [and] the Central Public Interest Scientific Institution Basal Research Fund.”

All authors are affiliated with Chinese government research institutes or state-linked laboratories, including the Chinese Academy of Agricultural Sciences and China’s National High Containment Laboratory for Animal Disease Control and Prevention.

Bottom Line

The paper confirms that China is now testing mRNA vaccine platforms directly in livestock, including milk-producing animals, using live avian influenza viruses under high-containment laboratory conditions.

The study documents the use of modern mRNA technology not only in humans or laboratory animals, but in food-supply species that interface directly with agriculture, trade, and public health systems.

Category:

Uncategorized

Tagged with:

Canada Builds Live SARS-CoV-2 Viruses From Computer Code Alone That ‘Can Be Used For Gain-of-Function Research’: Journal ‘Viruses’


A closed pandemic loop of digital design, synthetic GOF viruses, and government-controlled verification.

A new peer-reviewed study published in the journal Viruses says that publicly funded Canadian laboratories digitally designed full-length SARS-CoV-2 genomes, chemically synthesized them using commercial services, and generated live, replication-competent coronaviruses without starting from a natural virus sample.

The paper, titled “Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening,” documents the alleged creation of infectious Delta and Omicron SARS-CoV-2 viruses from computer-designed genetic sequences alone.

Coming in the wake of the COVID-19 pandemic—which killed millions of people worldwide and was linked by multiple intelligence agencies to laboratory research—the study raises national security concerns about the ability of government-funded institutions to create replication-competent pandemic viruses from digital sequence data alone, using commercial infrastructure with limited public oversight.

In light of these capabilities, the study also raises the possibility that governments could define, simulate, and respond to a biological threat almost entirely within digital and laboratory frameworks—leaving the public reliant on official interpretation rather than independently observable evidence.

Viruses Built from Computer Code Alone

The authors state that they did not rely on physical viral isolates to create the viruses.

Instead, they used commercial DNA synthesis services to generate the entire coronavirus genome:

“We opted to use cDNA chemical synthesis services to generate full-length wild-type and reporter Delta and Omicron clones.”

They further explain:

“DNA synthesis is a viable method to rapidly generate coronavirus cDNAs and recombinant viruses.”

Those synthesized genomes were then said to be used to generate live viruses:

“Clone-derived Delta and Omicron wild-type and reporter viruses were successfully rescued and showed replication kinetics comparable to patient-derived isolates.”

The study claims that the resulting viruses were infectious and capable of sustained replication in cell culture.

The paper emphasizes that the same system can be used to generate new viral variants based solely on sequence data:

“DNA synthesis is a viable and rapid option to generate reverse genetic systems for wild-type and reporter viruses using sequence information alone.”

Acknowledged Gain-of-Function Capability

In the Discussion section, the authors explicitly acknowledge that the methodology they used qualifies as gain-of-function (GOF) capable research:

“It is important to acknowledge that the novel approach described in this study—generating replication-competent viruses from synthetic DNA while introducing heterogeneous gene functions—can be used for ‘gain-of-function’ research.”

Where the Viruses Were Said to Be Created

All work involving purportedly live SARS-CoV-2 was conducted in Canada at a high-containment facility:

“All the experiments involving infectious SARS-CoV-2 viruses were conducted at VIDO-InterVac in an approved Biosafety containment level 3 (BSL3) laboratory.”

VIDO-InterVac is part of the University of Saskatchewan, which is a central institutional hub for the research described in the paper.

Author Affiliations

The authors are affiliated with multiple Canadian institutions, including:

  • University of Saskatchewan (Department of Biochemistry, Microbiology, and Immunology; Vaccine and Infectious Disease Organization),
  • University of Alberta (Department of Cell Biology; Department of Medical Microbiology & Immunology; Li Ka Shing Institute of Virology),
  • Sunnybrook Research Institute (Toronto),
  • University of Toronto (Department of Laboratory Medicine and Pathobiology).

Public Funding Sources

The research was funded entirely through public Canadian funding, according to the paper’s funding disclosure:

“This research was funded by the Canadian Institutes of Health Research (CIHR)-funded Coronavirus Variants Rapid Response Network (CoVaRR-Net)… CIHR Operating COVID-19 Rapid Research Funding Opportunity—Therapeutics… and NSERC.”

Additional operational support came from:

“The Government of Saskatchewan… the Government of Canada through Prairies Economic Development Canada… and the Canada Foundation for Innovation Major Science Initiatives for its CL3 facility.”

What the Paper Establishes

The study documents, in the authors’ words, that:

  • Full-length SARS-CoV-2 genomes were digitally designed
  • Those genomes were chemically synthesized
  • Live, replication-competent coronaviruses were said to be generated from that synthetic DNA
  • The method is acknowledged to be usable for gain-of-function research
  • The work was publicly funded and conducted in Canadian government-supported laboratories

These facts are stated directly in the paper and do not rely on inference, speculation, or external interpretation.

Bottom Line

The new Viruses paper reveals that governments claim to possess the technical ability to define a virus digitally, synthesize it physically, and validate its behavior entirely within controlled laboratory systems—allowing modern pandemic response to operate almost entirely inside digital, synthetic, and laboratory environments.

That convergence raises unresolved questions about national security, transparency, independent verification, and how much trust the public is asked to place in closed scientific and governmental frameworks when responding to future biological threats.

The study aligns with earlier FOIA-released DARPA documents showing that U.S. biodefense systems were already built to synthesize viruses and manufacture mRNA countermeasures from sequence data alone, placing the Canadian work within a broader pre-existing digital pandemic infrastructure.

Category:

Uncategorized

Tagged with:

Trump Admin Keeps Ties to WHO Influenza System as U.S. Funds Bird Flu Gain-of-Function and Mass Vaccine Programs


Despite claiming to have withdrawn from the international organization.

Despite claiming to have formally withdrawn from the World Health Organization (WHO), the Trump administration has confirmed it is still in active discussions with the agency about participating in next year’s global influenza vaccine strain-selection process—at the same time the U.S. government is funding influenza bird flu gain-of-function research and a $500 million influenza vaccine initiative.

On January 22, the U.S. Department of Health and Human Services (HHS) announced that the United States had completed its withdrawal from the WHO, apparently ending all funding, recalling U.S. personnel, and terminating participation in WHO committees, governance bodies, and technical working groups.

During the same briefing, administration officials acknowledged that influenza remains an open channel for engagement.

Per CNN’s Thursday report:

“HHS left the door open to some continued collaboration, however. Asked if the US would participate in an upcoming WHO-led meeting to decide the composition of next year’s flu vaccines, the administration said conversations about that are still ongoing.”

The statement was made during a call with reporters following the withdrawal announcement.

This places influenza in a separate policy category—one where U.S. withdrawal exists on paper, but coordination with the same international decision system continues.

It raises questions about who is actually setting U.S. influenza policy, and why the one disease tied to global strain forecasting, pandemic modeling, and mass countermeasure production remains exempt from the break.

WHO Exit With Influenza Carve-Out

HHS stated the U.S. has:

  • Terminated all WHO funding
  • Recalled all personnel and contractors
  • Ceased participation in WHO technical working groups and governance bodies

Yet the administration declined to rule out involvement in the WHO’s influenza strain-selection process, which determines the purported viral lineages used in seasonal vaccines worldwide and shapes pharmaceutical manufacturing timelines.

Domestic Influenza Programs Continue to Expand

While negotiating ongoing coordination with the WHO, the federal government is simultaneously expanding influenza and bird flu research and vaccine programs inside the United States.

In 2025, HHS launched a $500 million federal influenza vaccine initiative described as a “gold standard” program designed to accelerate strain updates, enable rapid manufacturing, and support pre-pandemic deployment.

Federal agencies including the NIH, NIAID, USDA, and the Department of Defense continue funding laboratory research on avian and human influenza viruses that deliberately alter viral properties for study, including:

  • receptor binding changes,
  • mammalian transmissibility modeling,
  • chimeric viral backbones,
  • immune escape features.

These experiments are described in peer-reviewed publications and supported through federal research grants and biodefense contracting mechanisms.

U.S. agencies are also funding H5N1 bird flu vaccine platforms using reverse-genetics systems, chimeric viral constructs, and self-amplifying RNA technologies intended for pandemic countermeasure development.

Integrated Influenza Infrastructure

The WHO coordinates global influenza surveillance and strain forecasting.

The U.S. continues negotiating technical access to that system.

Federal agencies fund laboratory modification of influenza viruses and parallel vaccine platforms.

Pharmaceutical manufacturing and preparedness planning rely on the same surveillance and strain data.

Taken together, these disclosures show that despite the publicized WHO withdrawal, the United States remains functionally embedded in the WHO-centered influenza system—where global strain selection, federally funded virus engineering, and government-backed vaccine platforms converge inside the same international pandemic planning architecture.

Jan 23

Read full story

Bird Flu Takes Central Role in Trump Admin’s New $500 Million ‘Next-Generation’ Pandemic Vaccine Project

May 2, 2025

Read full story

NIAID Director Holds Patent for Bird Flu Pandemic Vaccine—as His Agency Creates Frankenstein Bird Flu Viruses in the Lab

October 10, 2025

Read full story

Trump’s CDC, FDA ‘Actively Participating’ in WHO Bird Flu Seminar Despite Executive Order to Withdraw U.S. from International Organization: STAT

February 25, 2025

Read full story

NIAID, DARPA, Bill Gates Intentionally Infect 80 Americans With Lab-Made Pandemic Influenza Virus: HHS Study

October 13, 2025

Read full story

U.S. Military Funds Intranasal Spray Self-Replicating sa-mRNA H5N1 Bird Flu Vaccine Built From Chimeric Viral Constructs: Journal ‘Nature Communications’

Jan 15

Read full story

WHO Vows ‘There Will Be Influenza Pandemics in the Future’

Jan 22

Read full story

WHO Instructs Governments to Track Online Anti-Vaccine Messaging in Real Time with AI: Journal ‘Vaccines’

December 29, 2025

Read full story

WHO Demands 90,000 Influenza and COVID PCR Tests Per Month Worldwide, Spanning 153 Labs in 131 Countries, Including U.S. CDC

December 23, 2025

Read full story

How the WHO Dictated the COVID-19 Pandemic—And How It’s Already Dictating the Coming Bird Flu Pandemic

December 10, 2025

Read full story

‘All Governance Functions Assumed by a Single Entity’: WHO-Backed Influenza Framework Outlines Command Merger During Next Pandemic

December 9, 2025

Read full story

WHO Rolls Out ‘Future’ COVID Pandemic Plan Using U.S. Labs for ‘Global Sentinel Surveillance’—Even After Trump Ordered Withdrawal

December 3, 2025

Read full story

WHO–Gates Blueprint for Global Digital ID, AI-Driven Surveillance, and Life-Long Vaccine Tracking for Every Person

December 2, 2025

Read full story

WHO Deploys National Pandemic Influenza Surveillance Grid in Egypt—270 Officers Trained for Real-Time Monitoring Across 30 Sentinel Sites

November 24, 2025

Read full story

WHO, CDC, Gates, and Oxford Were Used to Test Public ‘Compliance’ Strategies for ‘Lower-Quality Vaccines’ Before Any COVID-19 Jabs Existed: ‘PLOS Glob Public Health’ Journal

November 23, 2025

Read full story

WHO Builds International Pandemic Command System Through New Pathogen-Sharing Agreement

November 10, 2025

Read full story

*Articles credit Jon Fleetwood

Category:

Uncategorized

Tagged with:

NIAID Funds Gain-of-Function Study Engineering Novel Influenza Viruses With New Mammalian Pathogenic and Host-Entry Functions: Journal ‘Emerging Microbes & Infections’


Despite claims the U.S. has stopped bankrolling gain-of-function experiments.

A new peer-reviewed study published this week states that federally funded researchers genetically engineered viruses that gained biological functions not present in any naturally occurring strain, including new host-entry mechanisms, cross-species antigen display, and mammalian lethality.

In multiple cases, viral surface proteins from one species and virus family were deliberately inserted into the genetic backbone of an entirely different virus, creating laboratory chimeras that bridge species and viral lineages that do not naturally mix.

The paper, “Immunogenicity and Efficacy of a Rabies-Based Vaccine against Highly Pathogenic Influenza H5N1 Virus,” appears in Emerging Microbes & Infections.

The study documents three distinct categories of functional gain:

  1. transfer of influenza entry machinery into foreign viral backbones,
  2. reprogramming of rabies virus to perform influenza functions, and
  3. creation of new influenza chimeras that are lethal in mammals.

(Editor’s note: This article makes no claims about virology and/or terrain theory. It is reporting what NIAID-funded scientists claim to be doing with American taxdollars.)

Funding & Research Sites

The authors state:

“This study was supported by… the Center for Research on Influenza Pathogenesis and Transmission (CRIPT), one of the National Institute of Allergy and Infectious Diseases (NIAID) funded Centers of Excellence for Influenza Research and Response (CEIRR; contract # 75N93021C00014), and by NIAID contract SEM-CIVIC (contract number 75N93019C00051).”

NIAD is under the control of Director Jeffery Taubenberger, who is directing U.S. taxdollars toward influenza gain-of-function experiments while holding a patent for an influenza vaccine at the center of the Trump administrations $500 million influenza vaccine program.

This raises national security and conflict of interest concerns, as it represents the simultaneous creation of a lucrative problem and solution.

NIAD is under the authority of U.S. Health and Human Services (HHS), which is led by Robert F. Kennedy Jr.

Animal experiments were approved under:

“the Institutional Animal Care and Use Committee (IACUC) of Thomas Jefferson University (TJU).”

Influenza Host-Entry Functions Transferred Into a Different Virus

The authors state that they created a vesicular stomatitis virus whose native entry protein was replaced with influenza H5:

“VSV∆G-H5-GFP encoding either the clade 1 H5 (A/Viet Nam/1203/2004(H5N1) or the circulating clade 2.3.4.4b cow was generated as described.”

This describes a virus that now uses influenza hemagglutinin to enter host cells—a function VSV does not naturally possess.

It also represents a direct cross-species and cross-virus transfer of host-entry machinery, merging an avian influenza protein with a livestock-associated strain and a human-infecting viral backbone in a single engineered system.

Rabies Virus Reprogrammed to Display & Deliver Influenza Antigen

The study confirms that a rabies virus was engineered to express influenza H5:

“We developed a rabies virus-based H5 vaccine (RABV-H5) by insertion of a synthetic full-length codon-optimized HA ORF of the Influenza virus A/Vietnam 1203/2004(H5N1) into the BNSP333 rabies vaccine vector between the N and P genes.”

The authors further state:

“Presenting both RABV-G and the antigen of choice on the surface.”

This confirms that a neurotropic virus was genetically modified to perform a new influenza-specific function.

The lab construct combines a mammalian neurotropic virus with an avian influenza surface antigen, creating a synthetic cross-species hybrid that does not exist in nature.

Creation of Novel Influenza Viruses That Did Not Exist in Nature

The paper says that new influenza viruses were constructed by genome segment replacement:

“PR8-H5N1, a recombinant Puerto-Rico 8 influenza A virus (A/PR8) in which the HA and NA genomic segments have been replaced with the respective segments of H5N1.”

A second engineered virus is identified:

“Influenza virus A/PR8-H5N1 bovine/Ohio/439/2024 (2024).”

These viruses did not exist prior to laboratory construction.

Engineered Viruses Demonstrated Mammalian Pathogenicity

The authors report intranasal infection of mice with the engineered viruses:

“On days 104 or 150, mice were challenged by IN instillation with 0.05 ml of either 1E5 TCID50 of Influenza A/PR8-H5N1 (Viet Nam 1203 or Cow) or with 100 pfu of HPAI-H5N1 Viet Nam 1203 (2004) diluted in PBS+1% heat-inactivated FBS.”

They further confirm the dose was lethal:

“[O]n day 104 were challenged by IN instillation with a 1E5 pfu lethal dose of A/PR8-H5N1 Viet Nam 1203 virus (>100LD50).”

The paper documents viral replication in lungs:

“While unvaccinated mice had about 1E6 TCID50/ml of replicating virus in the lungs.”

And describes lung pathology:

“Severe and chronic bronchiolocentric infection with bronchiolar and peribronchiolar infiltration of lymphocytes, associated with interstitial pneumonitis and expanded alveolar wall due to edema and inflammation.”

Bottom Line

The new study makes clear that gain-of-function virus creation is allegedly still being carried out with U.S. taxpayer dollars, despite the national security and biosafety risks such work poses to the very population funding it.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

Why does the U.S. continue to fund the same experiments that are said to have caused the last pandemic?

June 19, 2025

Read full story

NIAID Director Holds Patent for Bird Flu Pandemic Vaccine—as His Agency Creates Frankenstein Bird Flu Viruses in the Lab

October 10, 2025

Read full story

Bird Flu Takes Central Role in Trump Admin’s New $500 Million ‘Next-Generation’ Pandemic Vaccine Project

May 2, 2025

Read full story

USDA–Iowa State University Lab-Engineer New Chimeric Bird Flu Viruses That Bind to Human Breast Tissue: ‘Journal of Dairy Science’

November 30, 2025

Read full story

USDA–NIH–University of Georgia–Mount Sinai Team Aerosolizes Lab-Engineered ‘Chimeric’ Influenza Frankenviruses: Journal ‘npj Vaccines’

November 28, 2025

Read full story

NIAID Funds Creation of Chimeric H5N1 Bird Flu Viruses With Modified Cleavage Sites and Enhanced Mammalian-Cell Expression: ‘npj Vaccines’

November 29, 2025

Read full story

Trump Admin Doubles Down on EO Exemptions for Gain-of-Function Experiments: Journal ‘Nature Medicine’

Jan 17

Read full story

WHO Vows ‘There Will Be Influenza Pandemics in the Future’

Jan 22

Read full story

‘Critical Loophole’ in U.S. Biosecurity Rules Allows Legal Assembly of 1918 Spanish Flu Pandemic Virus DNA: Journal ‘Nature Communications’

Jan 16

Read full story

U.S. Military Funds Intranasal Spray Self-Replicating sa-mRNA H5N1 Bird Flu Vaccine Built From Chimeric Viral Constructs: Journal ‘Nature Communications’

Jan 15

Read full story

Portugal Runs H5N1 Bird Flu Outbreak Simulation—Echoing Pre-COVID Pandemic Exercises

Jan 13

Read full story

DARPA Uses AI to Push Viral Pandemic Outbreak Modeling From Weeks to Days

Jan 9

Read full story

Bill Gates’ CEPI Revives Moderna mRNA Bird Flu Vaccine Development With $54M Investment After HHS Terminated Funding

December 19, 2025

Read full story

Saudi Arabia Bets on 2026 Bird Flu Pandemic, Ramps Up Domestic Vaccine Production Amid International H5N1 Gain-of-Function Fears

October 30, 2025

Read full story

*Article credits Jon Fleetwood

Category:

Uncategorized

Tagged with:

WHO Vows ‘There Will Be Influenza Pandemics in the Future’. Imagine That.


Public health forecasting—or orchestration?

On Wednesday, the World Health Organization (WHO) published an influenza fact sheet in which it declared that influenza pandemics are on the horizon, emphasizing bird flu.

In a document titled “Influenza (avian and other zoonotic),” the WHO did not say that it thinks an influenza pandemic is coming.

It did not say a future pandemic is a possibility.

The unelected foreign organization stated its coming is a fact, writing:

There will be influenza pandemics in the future, but when and with which virus, as well as where and how they will spread, is difficult to predict. They can have significant health, economic and social consequences. An influenza pandemic arises when an influenza virus emerges with the ability to cause sustained human-to-human transmission, and the human population has little to no immunity against the virus.

Whether currently circulating avian, swine and other influenza viruses will result in a future pandemic is unknown. However, the diversity of zoonotic influenza viruses that have caused human infections necessitates strengthened surveillance in both animal and human populations, thorough investigation of every zoonotic infection and pandemic preparedness planning.

The WHO financially benefits from pandemics.

The org received approximately $7.9 billion in total funding during the 2020-2021 biennium, exceeding its $5.84 billion approved budget by 36% due to massive COVID-19 emergency contributions.

Of this, around $3 billion was specifically for COVID-19 operations, marking an unprecedented surge from pre-pandemic levels.

A top contributor to the WHO is Bill Gates, who recently—through his Coalition for Epidemic Preparedness Innovations (CEPI)—invested $54.3 million to support Moderna’s new mRNA-based pandemic H5 avian influenza “bird flu” vaccine candidate, mRNA-1018.

Gates also financially backs biolabs said to be performing gain-of-function experiments on bird flu pathogens.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

The Gates Foundation and HHS have also been funding experiments said to be deliberately infecting American adults with a lab-grown pandemic influenza virus at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

If the WHO’s pandemic warnings are being issued inside a funding ecosystem that profits from crisis response—while those same donors bankroll laboratories now linked by governments to pandemic creation and fund programs that deliberately infect Americans with lab-grown influenza—then the line between public health forecasting and systemic orchestration is no longer defensible.

NIAID, DARPA, Bill Gates Intentionally Infect 80 Americans With Lab-Made Pandemic Influenza Virus: HHS Study

October 13, 2025

Read full story

Bill Gates’ CEPI Revives Moderna mRNA Bird Flu Vaccine Development With $54M Investment After HHS Terminated Funding

December 19, 2025

Read full story

WHO Instructs Governments to Track Online Anti-Vaccine Messaging in Real Time with AI: Journal ‘Vaccines’

December 29, 2025

Read full story

WHO Demands 90,000 Influenza and COVID PCR Tests Per Month Worldwide, Spanning 153 Labs in 131 Countries, Including U.S. CDC

December 23, 2025

Read full story

How the WHO Dictated the COVID-19 Pandemic—And How It’s Already Dictating the Coming Bird Flu Pandemic

December 10, 2025

Read full story

‘All Governance Functions Assumed by a Single Entity’: WHO-Backed Influenza Framework Outlines Command Merger During Next Pandemic

December 9, 2025

Read full story

WHO Rolls Out ‘Future’ COVID Pandemic Plan Using U.S. Labs for ‘Global Sentinel Surveillance’—Even After Trump Ordered Withdrawal

December 3, 2025

Read full story

WHO–Gates Blueprint for Global Digital ID, AI-Driven Surveillance, and Life-Long Vaccine Tracking for Every Person

December 2, 2025

Read full story

WHO Deploys National Pandemic Influenza Surveillance Grid in Egypt—270 Officers Trained for Real-Time Monitoring Across 30 Sentinel Sites

November 24, 2025

Read full story

WHO, CDC, Gates, and Oxford Were Used to Test Public ‘Compliance’ Strategies for ‘Lower-Quality Vaccines’ Before Any COVID-19 Jabs Existed: ‘PLOS Glob Public Health’ Journal

November 23, 2025

Read full story

WHO Builds International Pandemic Command System Through New Pathogen-Sharing Agreement

November 10, 2025

Read full story

Bird Flu Research Explodes 1,000% Worldwide—WHO, CDC, and EcoHealth Lead Rapid Expansion: ‘Journal of Infection and Public Health’

November 3, 2025

Read full story

WHO Quietly Reactivates Global Influenza Pandemic Apparatus for Bird Flu: ‘Journal of Infectious Diseases’

October 18, 2025

Read full story

WHO Runs 2-Day Pandemic Simulation: ‘Exercise Polaris’

April 8, 2025

Read full story

Trump’s CDC, FDA ‘Actively Participating’ in WHO Bird Flu Seminar Despite Executive Order to Withdraw U.S. from International Organization: STAT

February 25, 2025

Read full story

Gates Pours $3.3M Into mRNA Purification Tech—Admitting COVID Vaccine Impurity Problem as Platform Becomes Permanent

December 17, 2025

Read full story

Gates Holds $254 Million in Big Oil Investments Despite Blaming the Industry for ‘Climate Change’

Jan 21

Read full story

*Article credits Jon Fleetwood

Category:

Uncategorized

Tagged with:

Texas Air-Drops Live Virus-Containing Edible Rabies Vaccines Over Cities from Aircraft—’Leaving Persons at Risk for Vaccine Exposure and Vaccine Virus Infection’ Uninformed and with No Consents: CDC


Animals that ingest the oral vaccine are said to be contagious to other animals and humans for over a month.

On January 6, 2012, Brig. Gen. William L. Smith, Director Joint Staff and Commander, Domestic Operations for Joint Force Headquarters of Texas (second from left) met with members of the Texas State Guard and received an overview of the annual Texas Oral Rabies Vaccination Program in Zapata, Texas. Since the program’s inception in 1995, more than 39 million doses of the oral rabies vaccine, Raboral V RG, have been distributed over approximately 540,000 square miles of Texas. (U.S. Army Photo photo by Laura L. Lopez/Wikimedia Commons).

The Texas Department of Health and Human Services (DHS) has begun its annual distribution of RABORAL V-RG®, an oral rabies vaccine (ORV) bait—dropping the live laboratory-made virus from airplanes over Texas, as well as distributing it by hand.

The $2 million annual project is funded by the State of Texas and the United States Department of Agriculture Animal and Plant Health Inspection Service/Wildlife Services.

The U.S. Centers for Disease Control and Prevention (CDC) has known for over a decade that the RABORAL edible vaccine leaves “persons at risk for vaccine exposure and vaccine virus infection.”

Yet the department still allows millions of live genetically modified virus baits to be dispersed over communities, forests, and waterways each year without public notice, informed consent, or comprehensive biosafety oversight—posing potential risks to human health, wildlife, and national biosecurity.

Americans are being involuntarily exposed to laboratory-engineered pathogens capable of infecting multiple species, with no transparent risk disclosure or opt-out mechanism.

A DHS press release reads:

Texas Department of State of Health Services will expand anti-rabies efforts around the El Paso area in January during the agency’s 32nd annual Oral Rabies Vaccination Program. Aerial bait distribution, which occurs along much of the Texas-Mexico border, was increased last year to include far West Texas as a response to the Arizona Fox rabies variant that is now established in New Mexico and within 150 miles of the Texas border.

In addition to those continued flights this year, rabies vaccine baits will also be distributed by hand in targeted areas around the city.

The rabies vaccine bait air drop will begin with flights from Alpine on Jan. 16, with additional flights slated to originate from Del Rio International Airport on Jan. 21, weather permitting. The vaccine bait, manufactured by Boehringer Ingelheim Animal Health USA Inc., is enclosed in a small plastic packet (similar to a fast-food ketchup package) dipped in fish oil and fish-meal crumbles to attract wild canids, like coyotes and foxes.

Between six and nine flights are scheduled per day during the two-week operation, with airdrop aircraft flying at 500 to 1,000 feet above ground level and dropping roughly 693,600 oral rabies vaccine baits at 50 baits per square mile. ORVP’s Border Maintenance Zone includes 19 Texas counties including El Paso, Hudspeth, Culberson, Jeff Davis, Presidio, Brewster, Pecos, Terrell, Val Verde, Kinney, Maverick, Zavala, Dimmit, Webb, Zapata, Starr, Hidalgo, Cameron and Willacy.

In addition to the hand-distribution efforts in the El Paso area, baits will also be distributed by hand in parts of Cameron, Hidalgo, Starr and Willacy counties.

The U.S. Department of Agriculture warns humans “should leave [the live-virus containing edible vaccine] undisturbed if they are encountered.”

  • If people come in contact with the bait, “they should immediately wash the contact area with warm water and soap.”
  • Dogs that consume the bait “may experience a temporary upset stomach.”

A July 2019 peer-reviewed study in Vaccineconfirms the RABORAL oral rabies vaccine:

  • is a genetically engineered chimeric “Frankenstein” human virus expressing a rabies gene,
  • sheds for weeks in multiple species,
  • was not tested for live virus persistence,
  • can potentially infect non-target animals and humans,
  • and was studied by researchers financially tied to its sale.

Most alarmingly, the study confirmed that virus DNA from the edible vaccine can be detected in both oral and rectal swabs post-inoculation in most animals, “followed by a resurgence of shedding between days 17 and 34 in some species.”

This means animals that ingest the oral vaccine are said to be contagious to other animals and humans for over a month.

On January 6, 2012, Texas State Guard member, Private Paul Pettit of the 3rd Battalion, 1st Regiment takes part in one of the many flights that assists in the aerial distribution of Raboral V RG, during a 10-day Oral Rabies Vaccination Program. With statistics showing a drastic reduction in rabies cases the goal of this program is to create zones of vaccinated coyotes and gray foxes along the leading edges of the epizootics stopping the spread of the virus. (U.S. Army photo by Laura L. Lopez/Wikimedia Commons).

A September 2017 Veterinary Research publication confirms that the live virus in RABORAL edible vaccines actively replicates in animals after ingestion, that horizontal transmission of the vaccine virus between animals has occurred, and that humans have been infected with vaccine-derived vaccinia following bait exposure.

The same study shows that RABORAL baits deliberately disperse tetracycline—a toxic ingredient in the vaccine—into the environment as a biomarker, where it accumulates in animal bone and teeth, can misrepresent true vaccination, and is acknowledged to carry potential ecotoxicity and antimicrobial-resistance risks with long-term use.

In the name of “wildlife management,” Texas authorities are blanketing cities with what are said to be live virus-containing packets without full public consent.

How many Texans have been informed that they are living inside an ongoing, state- and federally funded environmental release of a live, laboratory-engineered virus documented to replicate, spread between animals, persist in bodily secretions, and infect humans—without informed consent or any meaningful ability to refuse exposure?

USDA Drops Live Virus-Containing Rabies Edibles from Helicopters, Airplanes Across United States—’Leaving Persons at Risk for Vaccine Exposure and Vaccine Virus Infection’: CDC

October 16, 2025

Drones Spray ‘Self-Spreading’ COVID-19 Vaccine for ‘Large-Area Inoculation of Humans’ in ‘DEFUSE’ EcoHealth/DARPA Project

December 24, 2024

Operation ‘Large Area Coverage’ (LAC): U.S. Gov’t Covertly Sprays Airborne Toxic Chemical Agent on Unsuspecting Americans in Secret Bioweapons Experiment

October 31, 2024

‘Operation Sea-Spray’: U.S. Gov’t Secretly Sprays Deadly Bacteria Cloud on Americans in Bioweapons Experiment

January 3, 2025

Read full story

PREP Act Empowers Gov’t to ‘Administer’ Drugs, Biological Products, Devices to Citizens in Secret

December 31, 2024

Read full story

CDC, NIAID, DARPA Infect 36 People with Lab-Made Epidemic Influenza Virus: Journal ‘Influenza and Other Respiratory Viruses’

October 14, 2025

Read full story

NIAID, DARPA, Bill Gates Intentionally Infect 80 Americans With Lab-Made Pandemic Influenza Virus: HHS Study

October 13, 2025

Read full story

American Bioweapons: Then & Now

May 29, 2024

Read full story

Investigation Into U.S. Military Bioweapons-Origin of Tick-Borne Lyme Disease Successfully Added to 2026 National Defense Authorization Act

December 12, 2025

Read full story

Over 100 ‘BSL-4’ Bioweapons Labs Now Operate Worldwide, with More Under Construction: ‘Journal of Public Health’

October 23, 2025

Read full story

Measles Vaccine and Gain-of-Function: The Inconvenient Truth About CD150/CD46 Tropism Shift

March 5, 2025

Read full story

Texas Gave 15,000 More MMR Shots This Year—Now It Has More Measles Cases Than the Entire U.S. Had in 2024

March 25, 2025

Read full story

Free Measles Vaccine Campaign Followed by Measles Outbreak in Texas County

February 17, 2025

Read full story

*Article credits by Jon Fleetwood

Category:

Uncategorized

Tagged with:

U.S. Military Funds Intranasal Spray Self-Replicating sa-mRNA H5N1 Bird Flu Vaccine Built From Chimeric Viral Constructs: Journal ‘Nature Communications’


U.S. government is not slowing its push toward intranasal self-replicating RNA vaccine technology.

A U.S. military–funded research program has developed an intranasal, self-replicating RNA (sa-mRNA) vaccine targeting H5N1 avian influenza, built using chimeric viral constructs assembled through reverse genetics.

The work was disclosed in a 2026 Nature Communications paper and explicitly funded through a U.S. Army–administered biodefense contracting mechanism.

The vaccine is said to force cells to produce H5N1 bird flu antigen while simultaneously producing viral replication enzymes that copy the self-amplifying RNA inside the cell.

The U.S. government is funding the creation of next-generation bird flu vaccines while funding the creation of purported chimeric “Frankenstein” bird flu viruses.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

Why is the government making the bird flu pandemic problem and solution at the same time, just like it was doing with coronaviruses before the COVID-19 outbreak?

What Was Built

The researchers are said to have engineered a self-amplifying RNA vaccine that uses a Venezuelan equine encephalitis virus (VEEV) replicon backbone into which they inserted influenza hemagglutinin (HA) genes from H5N1 (and H7N9).

The RNA construct was packaged in a cationic nanostructured lipid carrier and designed for intranasal spray delivery.

This is not conventional mRNA.

Self-amplifying RNA replicates inside host cells, increasing antigen production after administration.

While the construct is described as replication-defective (it lacks viral structural genes and cannot form a spreading virus), it is nonetheless a synthetic viral system built from components of different viruses.

Reverse Genetics & Chimeric Design

The platform was produced using reverse genetics—starting from gene sequences, cloning them into plasmids, and generating RNA by in-vitro transcription.

In practical terms, this means influenza genetic material was deliberately engineered into a VEEV replicon, creating a chimeric viral construct designed to self-amplify once inside cells.

This approach represents intentional genetic assembly of viral parts to achieve a specific biological effect.

Intranasal Spray Delivery

The vaccine was purpose-built for intranasal (IN) administration, a route the authors emphasize for inducing mucosal and lung-resident immune responses that intramuscular vaccines do not generate.

The paper reports distribution throughout the upper and lower respiratory tract, with some material swallowed into the gastrointestinal tract—a confessed feature of intranasal dosing.

This delivery choice matters because it places a self-replicating RNA system directly onto respiratory mucosa, rather than confining it to muscle tissue.

The Virus Target: H5N1

The primary antigen target is H5N1 avian influenza, repeatedly framed in the paper as a pre-pandemic threat.

Ferret challenge experiments involved high-dose intranasal exposure to influenza, with the sa-mRNA platform reported to protect against severe disease.

The study positions the platform as rapidly deployable, emphasizing scalability, thermostability, and potential for stockpiling—language consistent with pandemic preparedness, not routine seasonal vaccination.

Who Funded It—& How

The paper states plainly that the work was “sponsored by the US Government under Other Transaction number W15QKN-16-9-1002.”

W15QKN-16-9-1002 is a U.S. Army Contracting Command–New Jersey Other Transaction Agreement (OTA) established under Section 815 of the 2016 National Defense Authorization Act.

The agreement created the Medical CBRN Defense Consortium (MCDC) to fund research and development of medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats.

Key points from the OTA itself:

  • The agreement is administered by the U.S. Army Contracting Command on behalf of the Department of Defense.
  • It authorizes the government to select, direct, and fund specific projects it deems necessary.
  • The scope explicitly includes vaccines, medical countermeasures, and manufacturing platforms designed for rapid response to biological threats.
  • The estimated value of projects issued under the agreement is up to $10 billion, with a 20-year term.

The research was supported through a military biodefense R&D framework designed to develop deployable medical technologies.

Bottom Line

The Nature paper confirms that a U.S. military–administered funding program supported the development of an intranasal, spray-form self-replicating sa-mRNA vaccine built from chimeric viral constructs that include H5N1 influenza genes.

The authors emphasize speed, scalability, and deployment readiness.

This is best understood not as a routine flu-vaccine study, but as a biodefense-driven platform demonstration: a synthetic, self-amplifying viral system designed for rapid respiratory deployment in a future pandemic scenario.

At a time when governments now acknowledge that lab-engineered pathogens can spark global crises, the United States is simultaneously funding the creation of chimeric avian influenza systems and the intranasal self-replicating technologies positioned to counter them—collapsing the line between pandemic threat creation and pandemic response into the same military-run pipeline.

Category:

Uncategorized

Tagged with:

U.S. Intelligence Classified and Redacted Findings on COVID-19 PCR Tests: New FOIA Documents


New records show top U.S. nuclear, national security laboratories scrutinized primers used to define the pandemic—but hid the results.

Newly released Department of Energy (DOE) records obtained by U.S. Right to Know through a Freedom of Information Act (FOIA) requenst show that U.S. federal intelligence agencies classified and redacted the results of an internal review of COVID-19 PCR test primers, even as those tests were used to define “cases,” drive emergency policy, and justify unprecedented social and economic controls.

The documents reveal that during the pandemic, the U.S. government quietly subjected PCR test primer sets—the molecular components that determine what PCR tests detect—to classified scrutiny by top national security laboratories, while withholding the findings from the public under national-security and intelligence exemptions.

At the center of the release is a classified internal communication titled “DRAFT memo on Primer Sets,” circulated through the DOE’s Office of Intelligence and Counterintelligence and reviewed by assay experts at Lawrence Livermore National Laboratory, Los Alamos National Laboratory, and Pacific Northwest National Laboratory.

The memo itself remains classified.

Its conclusions were redacted.

No public explanation was ever provided.

PCR Testing Was Treated as a Classified Intelligence Issue

PCR tests do not detect an intact virus and do not prove infection.

They work by using short genetic sequences—primers—to bind to matching genetic material and amplify it until a signal is detected.

What a PCR test detects depends entirely on what its primers bind to.

The DOE records show that this foundational question—what COVID-19 PCR tests were actually detecting—was handled not as a public scientific matter, but as a classified intelligence issue.

One internal email chain explicitly references a classified document titled:

“FW: (S//REL) DRAFT memo on Primer Sets”

Another message states that the memo was reviewed by a specialist:

“I had our newly assay expert review this and provide the comments within.”

The routing shows coordination across DOE intelligence offices and U.S. national security laboratories.

The content of the memo, the concerns it addressed, and the conclusions it reached are all withheld from public release.

What the Government Did Not Disclose

Throughout the pandemic, the public was repeatedly told that COVID-19 PCR testing was reliable, specific, and settled.

Questions about PCR design were often dismissed as misinformation.

The DOE records show the opposite posture inside government: PCR primer design was serious enough to warrant classified review by nuclear-era national laboratories, with the results deemed sensitive enough to be redacted under national-security and intelligence-source protections.

DOE explicitly justified withholding the information by citing risks to national security and intelligence methods, and assigned declassification dates decades into the future.

There is no indication in the records that the findings were shared with public-health agencies, published in scientific journals, or communicated to the public.

Why PCR Primer Design Is Existential, Not Technical

PCR testing formed the backbone of the pandemic response.

PCR “positives” were treated as synonymous with infection and were used to define:

  • COVID “cases”
  • Community spread
  • Hospital surges
  • Lockdowns and emergency orders
  • Vaccine emergency authorizations

If PCR primers bind to viral genetic material, positives reflect virus detection.

If PCR primers bind to human genetic material, positives can reflect the person being tested.

That distinction determines whether a “case” is an infection—or merely a genetic detection.

What the CDC’s PCR Primer Actually Aligns To

An independent BLAST analysis was run of the CDC’s SARS-CoV-2 forward PCR primer.

The results show that the primer has multiple perfect and near-perfect matches to the human genome, including:

  • Repeated 13–16 base stretches with 100% identity to human DNA
  • Longer alignments exceeding 94–95% identity across multiple human chromosomes

In plain terms: the CDC’s COVID-19 PCR primer can bind to human genetic material.

That establishes a biological mechanism by which a PCR test administered “for COVID-19” can return a positive result by amplifying human DNA or RNA rather than viral RNA.

If that occurs, the test still produces a positive signal.

The result is still recorded as a “COVID case.”

But no infection has been detected.

The “case” is a human genetic detection.

Why This Explains the Secrecy

The DOE records show that this was not ignored.

It was escalated—and then classified.

National security laboratories are not tasked with reviewing PCR primer sets unless the implications are systemic.

If the test used to define a global pandemic can generate positives without detecting a virus, public disclosure would collapse the legitimacy of case counts, emergency powers, and pandemic policy itself.

The records show that U.S. intelligence examined the issue.

They also show that the findings were classified, redacted, and withheld from the public.

The classification of PCR findings is especially significant given that no U.S. agency has ever independently verified the original clinical sample from which the SARS-CoV-2 genetic sequence was derived.

The United States accepted a digital genetic code supplied by the Chinese government—without access to the physical lung sample it was allegedly sequenced from—and relied on PCR testing and that same in-silico sequence to define cases, drive emergency policy, and later encode spike protein into hundreds of millions of vaccine doses.

That secrecy is even more consequential given that U.S. military planners had already built—and quietly funded—a DARPA-backed pandemic pipeline designed to treat digital genetic sequences as functional viruses, synthesizing infectious clones and mass-producing mRNA countermeasures without requiring a verified physical pathogen, meaning both COVID “case” detection and the subsequent vaccine rollout rested on the same unverified, in-silico genetic foundation.

Dr. Kary Mullis, the late inventor of the PCR test, said in a 1997 interview (here) that his test should not be used to determine whether a subject is infected with a virus.

This is because the test “can find almost anything in anybody” if its parameters are set high enough, tainting the results, according to the Nobel Prize winner.

“Anyone can test positive for practically anything with a PCR test. If you run it long enough… you can find almost anything in anybody,” Dr. Mullis said. “It doesn’t tell you that you’re sick.”

Mullis’s warning matters because it confirms that PCR was not designed to establish clinical infection, meaning a pandemic built on PCR “cases” can reflect amplified genetic signals rather than illness—a vulnerability that could be serious enough to later draw classified scrutiny from U.S. national security laboratories.

What the Records Prove—& What They Imply

The documents do not release the primer memo.

They do not disclose the conclusions.

They do not quantify how many PCR positives may reflect human material.

They do prove that:

  • COVID-19 PCR test primers were scrutinized by U.S. intelligence
  • Top national security laboratories were involved
  • The findings were classified and redacted
  • The public was never informed

Combined with sequence-alignment evidence showing that the CDC’s PCR primer binds to human DNA, the implication is unavoidable:

The U.S. government privately examined whether the test used to define the pandemic could generate “cases” without detecting infection—and then classified the answer.

The DOE records were released to U.S. Right to Know under FOIA request HQ-2025-03244-F.

The primer alignment is reproducible using the CDC’s published primer sequence and the human reference genome.

The public was told PCR testing was settled science.

The documents show the government didn’t treat it that way behind the scenes.

And whatever they found, they made sure we were never allowed to see it.

Category:

Uncategorized

Tagged with:

Portugal Runs H5N1 Bird Flu Outbreak Simulation—Echoing Pre-COVID Pandemic Exercises


Patients refusing to use personal protective equipment, like masks, defined as “threats.”

Portuguese health authorities conducted a formal avian influenza (H5N1) simulation exercise in early 2025 to test how primary health care units would respond to a bird flu outbreak, according to a study published last week in Acta Médica Portuguesa and indexed by the U.S. National Library of Medicine.

The exercise comes as bird flu is simultaneously being advanced through expanded PCR surveillance, laboratory-engineered H5N1 research, and revived mRNA vaccine programs, raising questions given the similar convergence of testing, research, and preparedness measures that preceded COVID-19.

The exercise took place on February 3, 2025, and was coordinated by the Infection Prevention and Control Programme responsible for primary health care units in Northern Lisbon, within the Santa Maria Local Health Unit.

According to the authors, the event was a tabletop exercise—a structured simulation used to rehearse decision-making during hypothetical outbreaks—designed to assess whether frontline clinics could identify, isolate, and manage patients during high-risk infectious disease scenarios.

What Was Simulated

The exercise explicitly included avian influenza A (H5N1) as one of its outbreak scenarios, alongside Marburg virus disease and measles.

Participants were initially presented with blinded clinical and epidemiological information and asked to respond without knowing the pathogen in advance.

The diagnoses—including H5N1—were disclosed only after discussion.

Who Participated

Representatives from 15 primary health care units, accounting for 83% of clinics in the region, took part in the exercise.

Participants included healthcare professionals and unit leadership responsible for infection control and patient flow.

What the Exercise Tested

The simulation evaluated:

  • Early identification of suspected infectious cases
  • Availability of isolation rooms and isolation pathways
  • Staff familiarity with mandatory reporting and isolation procedures
  • Communication between clinics and external health authorities
  • Barriers to compliance, including “uncooperative” patients and language obstacles.

‘Uncooperative’ Patients as a Defined ‘Threat’

The authors explicitly frame patient non-compliance as a threat to outbreak control during the simulation, rather than as a secondary or peripheral challenge.

They write:

“[L]anguage barriers or non-cooperative patients (e.g., refusing to use personal protective equipment) were seen as threats to implement procedures correctly.”

In the study’s structure, this language also appears under the “Threats” category of the SWOT analysis—placing patient behavior alongside infrastructure failures and staffing shortages as factors that could actively undermine outbreak response.

The paper also notes that frontline clinics lacked personnel trained to manage or redirect patients once non-compliance occurred:

“[C]oncerns were raised about non-healthcare professionals in several units, such as security guards and administrative assistants, lacking training to identify potential infectious diseases and guide patients towards isolation circuits and/or alert healthcare workers.”

This framing treats refusal—specifically refusal to use personal protective equipment—as an anticipated operational risk during an infectious disease response scenario.

The authors do not describe voluntary refusal as a matter of patient autonomy.

Instead, refusal is listed as an obstacle to the correct implementation of procedures, implying a need for enforcement capacity that clinics were found to lack.

No mitigation strategies for patient refusal are proposed in the paper.

No limits on enforcement authority are discussed.

The simulation record shows that non-cooperation was expected, identified in advance, and formally categorized as a threat within a modeled H5N1 outbreak response.

Why This Exercise Draws Attention

Although the simulation occurred in early 2025, the study was submitted in July 2025, accepted in December, and published online January 8, 2026, placing it into the medical literature at a time when international concern over bird flu preparedness is intensifying.

The timing and structure of the exercise are notable.

In the years preceding COVID-19, global health institutions conducted high-level pandemic simulations—including SPARS Pandemic 2025–2028 and Event 201—that modeled coronavirus outbreaks, public messaging challenges, and emergency countermeasures shortly before those scenarios became reality.

This Lisbon exercise follows the same pattern:

  • a named pathogen,
  • a simulated outbreak,
  • documented preparedness gaps,
  • and publication after the fact to formalize the response framework.

The study documents preparedness planning.

It confirms that bird flu is now being actively rehearsed as a plausible next pandemic scenario, not only in abstract policy discussions, but through operational simulations involving frontline civilian healthcare systems.

Was the exercise solely for preparedness, or does it function as early-stage coordination for future response architectures?

Category:

Uncategorized

Tagged with:

WHO VigiAccess Lists 5.8 Million COVID-19 Vaccine Adverse Event Reports


World Health Organization data show system-wide adverse event reports spanning neurological, cardiac, immune, gastrointestinal, and reproductive categories.

The World Health Organization’s VigiAccess pharmacovigilance database currently lists 5,811,685 individual adverse drug reaction (ADR) reports associated with COVID-19 vaccines as an active ingredient.

A Harvard Pilgrim Healthcare/HHS study confirms fewer than 1% of vaccine adverse events are reported, meaning the number could be closer to half a billion.

These reports are submitted by national drug regulators worldwide and categorized by affected body system.

Below is the full numerical breakdown exactly as listed in the database.

Reported Potential Side Effects by System Category

  • General disorders and administration site conditions
    3,435,222 reports (26%)
  • Nervous system disorders
    2,162,680 reports (16%)
  • Gastrointestinal disorders
    969,611 reports (7%)
  • Investigations (laboratory abnormalities, diagnostic findings)
    807,850 reports (6%)
  • Infections and infestations
    660,107 reports (5%)
  • Respiratory, thoracic, and mediastinal disorders
    559,163 reports (4%)
  • Skin and subcutaneous tissue disorders
    643,195 reports (5%)
  • Injury, poisoning, and procedural complications
    373,950 reports (3%)
  • Cardiac disorders
    334,064 reports (3%)
  • Psychiatric disorders
    253,443 reports (2%)
  • Blood and lymphatic system disorders
    240,517 reports (2%)
  • Vascular disorders
    245,846 reports (2%)
  • Reproductive system and breast disorders
    280,795 reports (2%)
  • Musculoskeletal and connective tissue disorders
    1,419,363 reports (11%)
  • Immune system disorders
    123,050 reports (1%)
  • Surgical and medical procedures
    121,374 reports (1%)
  • Metabolism and nutrition disorders
    103,797 reports (1%)
  • Eye disorders
    172,469 reports (1%)
  • Ear and labyrinth disorders
    153,026 reports (1%)

Lower-Frequency Categories Still Numerically Significant

  • Renal and urinary disorders
    47,767 reports
  • Endocrine disorders
    13,403 reports
  • Hepatobiliary disorders
    13,323 reports
  • Pregnancy, puerperium, and perinatal conditions
    14,180 reports
  • Congenital, familial, and genetic disorders
    4,533 reports
  • Neoplasms (benign, malignant, unspecified)
    17,770 reports
  • Product issues
    10,919 reports
  • Social circumstances
    47,909 reports

These figures represent submissions from national health authorities participating in the WHO’s global drug-safety monitoring program.

As of March 2025, 182 health authorities (national pharmacovigilance centers) participate in the WHO Program for International Drug Monitoring.

Each report may include multiple symptoms, meaning totals by category exceed the number of individual reports.

The scale and system-wide distribution of these reports are unprecedented for a single pharmaceutical product class in the VigiBase system.

Category:

Uncategorized

Tagged with:

Newly U.K.-Approved Self-Replicating COVID Jab ‘Kostaive’ Produces Spike Protein Detectable 28 Days After Vaccination: Journal ‘Biochemistry and Biophysics Reports’


samRNA-copying enzyme also produced in the body post-vaccination detected for at least 15 days, according to study.

Arcturus Therapeutics’s Kostaive (zapomeran, ARCT-154) self-amplifying mRNA COVID-19 vaccine is said to force cells in the body to produce SARS-CoV-2 spike protein—detectable in draining lymph nodes for at least 28 days—and a replicase enzyme that makes more copies of the vaccine mRNA, with the enzyme itself detectable for up to 15 days.

ARCT-154 was quietly approved by U.K. regulators over the weekend.

An April 2025 Biochemistry and Biophysics Reports publication confirms that the ARCT-154 spike protein was “detectable up to 28 days post-vaccination” in mice.

The ARCT-154 samRNA-replicating enzyme also produced in the body post-vaccination was detectable for “up to 15 days.”

The study reads:

The encoded spike protein reached its highest level approximately 3 days after vaccination and quickly disappeared from the rectus femoris muscle, the injection site. Although the spike protein levels also peaked at an early time point in the lymph nodes, it remained detectable 28 days after the vaccination and then disappeared by 44 days after the vaccination. Expression of nsP1, nsP2 and nsP4 was observed in the injected muscle and/or the lymph nodes for up to 15 days post-vaccination.

There were no samples taken at intermediate days like 30, 35, or 40, so we don’t know the exact day the vaccine-produced spike protein became undetectable.

The U.K. press release failed to mention any of this.

Are citizens being fully informed before they consent to this new pharmaceutical injection?

Why are government regulators not providing this information?

Can the Vaccinated Shed samRNA Onto the Unvaccinated?

Exosomes and extracellular vesicles (EVs) are released by cells as part of normal physiology and disease processes, shedding into various bodily fluids such as blood, urine, semen, amniotic fluid, and breast milk.

It is biologically plausible that sa-mRNA, spike protein, and replicase enzymes from Kostaive could be packaged into EVs and exosomes for shedding into bodily fluids—potentially amplified by the self-replicating nature of sa-mRNA—allowing their release into circulation and excretion via blood, sweat, saliva, or breast milk.

A December Science, Public Health Policy, and the Law study shows that spike protein produced by cells from the BioNTech/Pfizer mRNA COVID-19 vaccine is mainly released into the surroundings through extracellular vesicles (which include exosomes).

Moderna knew as early as 2017 that its mRNA vaccine lipid nanoparticles—which carry vaccine mRNA into cells and are used in samRNA jabs—enter the bloodstream and accumulate in the liver, spleen, kidneys, heart, and lungs.

A January 2023 Nature Reviews Drug Discovery paper co-authored by Moderna scientists bluntly admits that avoiding “unacceptable toxicity” in mRNA vaccines remains a major challenge, warning that “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs all present toxicity concerns” and that the way these vaccines spread through the body can cause harm due to “cell tropism and tissue distribution… and their possible reactogenicity.”

Can individuals injected with self-replicating vaccines spread sa-mRNA, spike protein, and replicase enzymes to others?

After those elements are shed onto the unvaccinated, will they become vaccinated?

Category:

Uncategorized

Tagged with:

Orwellian Tactics. WHO Instructs Governments to Track Online Anti-Vaccine Messaging in Real Time with AI: Journal ‘Vaccines’


Believe in vaccines or be targeted.

The World Health Organization (WHO) has demanded that governments surveil online information that questions the legitimacy of influenza vaccines and that they launch “countermeasures” against those who question the WHO’s vaccine dogma, in a November Vaccines journal publication.

The WHO’s largest funders are the U.S. government (taxpayers) and the Bill & Melinda Gates Foundation.

In the November publication, the WHO representatives do not argue for their beliefs in vaccines.

They do not attempt to interact with arguments against vaccines.

Instead, they call for governments to use artificial intelligence (AI) to monitor online opposition to injectable pharmaceuticals, and to develop ways to combat such opposition.

There is no persuasion, only doctrine.

The WHO paper reads:

“Vaccine effectiveness is contingent on public acceptance, making risk communication and community engagement (RCCE) an integral component of preparedness. The research agenda calls for the design of tailored communication strategies that address local sociocultural contexts, linguistic diversity, and trust dynamics.”

“Digital epidemiology tools, such as AI-driven infodemic monitoring systems like VaccineLies and CoVaxLies, offer real-time insight into misinformation trends, enabling proactive countermeasures.”

The WHO starts from the assumption that all vaccine skepticism is inherently false, pushing surveillance tools to track and catalog online dissent from those rejecting that creed.

The goal is not finding middle ground or even fostering dialogue.

It’s increasing vaccinations.

“The engagement of high-exposure occupational groups as trusted messengers is recommended to improve uptake.”

To accomplish this, governments “should” align “all” their messaging with the WHO’s denomination of vaccine faith.

“All messaging should align with WHO’s six communication principles, ensuring information is Accessible, Actionable, Credible, Relevant, Timely, and Understandable, to strengthen public trust in vaccination programmes [sp-non English].”

The WHO’s faith system requires not only that its own followers, but also non-followers inject themselves with drugs linked to injuries, diseases, hospitalizations, and deaths.

If your posts online oppose that faith system, they are targeted and labeled as “misinformation.”

You require “behavioural [sp-non English] intervention.”

You must be “counter[ed].”

“Beyond monitoring misinformation, participatory communication models that involve local leaders, healthcare workers, and veterinarians have shown measurable improvements in vaccine uptake and trust. Evidence-based behavioural [sp-non English] can complement these approaches to counter misinformation.”

The WHO is outlining an Orwellian control system where dissent is pathologized, belief is enforced by surveillance, and governments are instructed to algorithmically police thought in service of pharmaceutical compliance.

Category:

Uncategorized

Tagged with: